Dow Jones, S&P 500 gain on rate cut hopes as shutdown cancels key inflation, jobs reports
Prescient secures EMA Orphan Drug Designation for PTX-100 in CTCL
'Church-tech' firm Gloo Holdings makes $600m stock market debut
Prescient Therapeutics prepares for transformative year with new CEO and key FDA clearance